Community Feature

Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors

Mojun Zhu, et al., The Oncologist

This article describes a patient with high-grade pancreatic neuroendocrine tumor and BRCA1 germline mutation who had a significant response to Lutetium-177-Dotatate and summarizes the current state of clinical management of high-grade neuroendocrine tumors.




Taking the Longer View of COVID‐19

Bruce A. Chabner, MD Editor-in-Chief

What are the prospects for dealing with COVID‐19 more effectively in the future? This editorial addresses the question from the perspective of long‐term control of coronavirus infection.




Management of Cancer Patients During the COVID-19 Pandemic

Humaid O. Al‐Shamsi, et al., The Oncologist

Cancer patients have an increased risk of contracting COVID-19. This article addresses the challenges associated with managing cancer patients during the COVID-19 infection pandemic and suggests some practical approaches.




Cancer Research Ethics and COVID-19

Debu Tripathy, et al., The Oncologist

This editorial highlights the ethical challenges facing oncologists and clinical investigators during the global COVID-19 pandemic.




Systematic Review of Pediatric Oncology Phase I Trials

Debu Tripathy, et al., The Oncologist

This systematic review of pediatric oncology phase I trials describes the safety profile and response outcomes from recent trials, comparing cytotoxic and targeted trials in the era of targeted therapies.




Bruce A. Chabner, The Oncologist

As The Oncologist marks a milestone year, its 25th anniversary, we reflect on our good fortune to have been witnesses and participants in the remarkable expansion of oncological practice over the past quarter century, as molecular oncology and immunotherapy have changed cancer care. Our hope is that The Oncologist has been a worthwhile effort, and we give special thanks to our authors, readers, and dedicated staff.

*In celebration of our 25th anniversary we are pleased to provide all readers free access to all content.


Rishi Jain, et al., The Oncologist

Malnutrition and physical inactivity are common in advanced cancer patients and are associated with poor outcomes. This article reports on the interactions of nutrition and exercise with clinical trial outcomes.


Debu Tripathy, et al., The Oncologist

The SystHERs breast cancer study was a fully enrolled, prospective registry study that explored contemporary treatment patterns and outcomes in patients with HER2-positive metastatic breast cancer (MBC), resulting in one of the largest real-world datasets for this population and providing a unique opportunity to assess patients with de novo and recurrent HER2-positive MBC. This article reports baseline characteristics, treatment patterns, patient-reported outcomes, and clinical outcomes in these patient subsets.


João Godinho, et al., The Oncologist

Venous thromboembolism is a common complication of pancreatic cancer. This retrospective study was conducted to determine the incidence of VTE and to evaluate the ONKOTEV score as a VTE predictive tool in a pancreatic cancer population.